Efficacy, safety, and tolerability of augmentation pharmacotherapy with aripiprazole for treatment-resistant depression in late life: A randomised, double-blind, placebo-controlled trial

The Lancet

Volumn 386, Issue 10011, 2015, Pages 2404-2412

  Lenze, Eric J ^a   Mulsant, Benoit H ^b   Blumberger, Daniel M ^b   Karp, Jordan F ^c   Newcomer, John W ^d   Anderson, Stewart J ^e   Dew, Mary Amanda ^c   Butters, Meryl A ^c   Stack, Jacqueline A ^c   Begley, Amy E ^c   Reynolds, Charles F ^c,e  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF TORONTO   (Canada)

^c UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^d FLORIDA ATLANTIC UNIVERSITY   (United States)

^e UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARIPIPRAZOLE; PLACEBO; VENLAFAXINE; ANTIDEPRESSANT AGENT;

AGED; AKATHISIA; ARTICLE; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; FEMALE; HUMAN; INTENTION TO TREAT ANALYSIS; KNOWLEDGE; LIFE; MAJOR CLINICAL STUDY; MALE; MONTGOMERY ASBERG DEPRESSION RATING SCALE; PARKINSONISM; PHARMACIST; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REMISSION; SUICIDAL IDEATION; TREATMENT DURATION; TREATMENT OUTCOME; TREATMENT RESISTANT DEPRESSION; AKATHISIA, DRUG-INDUCED; CHEMICALLY INDUCED; CLINICAL TRIAL; DEPRESSIVE DISORDER, TREATMENT-RESISTANT; DRUG ADMINISTRATION; MIDDLE AGED; MULTICENTER STUDY; PARKINSON DISEASE; RECURRENT DISEASE;

AGED; AKATHISIA, DRUG-INDUCED; ANTIDEPRESSIVE AGENTS; ARIPIPRAZOLE; DEPRESSIVE DISORDER, TREATMENT-RESISTANT; DOUBLE-BLIND METHOD; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; MALE; MIDDLE AGED; PARKINSON DISEASE, SECONDARY; RECURRENCE; TREATMENT OUTCOME;

EID: 84952637611     PISSN: 01406736     EISSN: 1474547X     Source Type: Journal    
DOI: 10.1016/S0140-6736(15)00308-6     Document Type: Article

References (41)

1. HA Whiteford, L Degenhardt, J Rehm et al. Global burden of disease attributable to mental and substance use disorders: findings from the Global Burden of Disease Study 2010 Lancet 382 2013 1575 1586
2. ML Bruce, TR Ten Have, CF Reynolds 3rd et al. Reducing suicidal ideation and depressive symptoms in depressed older primary care patients: a randomized controlled trial JAMA 291 2004 1081 1091
3. J Eden, K Maslow, M Le, D Blazer The mental health and substance use workforce for older adults: in whose hands? 2012 The National Academy of Sciences Washington, DC
4. P Allard, L Gram, K Timdahl, K Behnke, M Hanson, J Sogaard Efficacy and tolerability of venlafaxine in geriatric outpatients with major depression: a double-blind, randomised 6-month comparative trial with citalopram Int J Geriatr Psychiatry 19 2004 1123 1130
5. A Schatzberg, S Roose A double-blind, placebo-controlled study of venlafaxine and fluoxetine in geriatric outpatients with major depression Am J Geriatr Psychiatry 14 2006 361 370
6. J Raskin, CG Wiltse, A Siegal et al. Efficacy of duloxetine on cognition, depression, and pain in elderly patients with major depressive disorder: an 8-week, double-blind, placebo-controlled trial Am J Psychiatry 164 2007 900 909
7. MH Trivedi, M Fava, SR Wisniewski et al. Medication augmentation after the failure of SSRIs for depression N Engl J Med 354 2006 1243 1252
8. DT Maust, DW Oslin, ME Thase Going beyond antidepressant monotherapy for incomplete response in nonpsychotic late-life depression: a critical review Am J Geriatr Psychiatry 21 2013 973 986
9. C Cooper, C Katona, K Lyketsos et al. A systematic review of treatments for refractory depression in older people Am J Psych 168 2011 681 688
10. CF Reynolds 3rd, MA Dew, LM Martire et al. Treating depression to remission in older adults: a controlled evaluation of combined escitalopram with interpersonal psychotherapy versus escitalopram with depression care management Int J Geriatr Psychiatry 25 2010 1134 1141
11. LS Schneider, PN Tariot, KS Dagerman et al. Effectiveness of atypical antipsychotic drugs in patients with Alzheimer's disease N Engl J Med 355 2006 1525 1538
12. T Hirose, Y Uwahodo, S Yamada et al. Mechanism of action of aripiprazole predicts clinical efficacy and a favourable side-effect profile J Psychopharmacol 18 2004 375 383
13. D Mamo, A Graff, R Mizrahi, CM Shammi, F Romeyer, S Kapur Differential effects of aripiprazole on D(2), 5-HT(2), and 5-HT(1A) receptor occupancy in patients with schizophrenia: a triple tracer PET study Am J Geriatr Psychiatry 164 2007 1411 1417
14. JC Nelson, GI Papakostas Atypical antipsychotic augmentation in major depressive disorder: a meta-analysis of placebo-controlled randomized trials Am J Geriatr Psychiatry 166 2009 980 991
15. DC Steffens, JC Nelson, JM Eudicone et al. Efficacy and safety of adjunctive aripiprazole in major depressive disorder in older patients: a pooled subpopulation analysis Int J Geriatr Psychiatry 26 2011 564 572
16. M Sheffrin, HC Driscoll, EJ Lenze et al. Pilot study of augmentation with aripiprazole for incomplete response in late-life depression: getting to remission J Clin Psychiatry 70 2009 208 213
17. B Rutherford, J Sneed, M Miyazaki et al. An open trial of aripiprazole augmentation for SSRI non-remitters with late-life depression Int J Geriatr Psychiatry 22 2007 986 991
18. SA Montgomery, M Asberg A new depression scale designed to be sensitive to change Br J Psychiatry 134 1979 382 389
19. CF Reynolds 3rd, MA Dew, BG Pollock et al. Maintenance treatment of major depression in old age N Engl J Med 354 2006 1130 1138
20. M Hamilton A rating scale for depression J Neurol Neurosurg Psychiatry 23 1960 56 62
21. AT Beck, M Kovacs, A Weissman Assessment of suicidal intention: the scale for suicide ideation J Consult Clin Psychol 47 1979 343 352
22. JE Ware SF-36 Health Survey: manual and interpretation guide 1993 The Medical Outcomes Trust Boston, MA
23. EG Kamel, G McNeill, MC Van Wijk Change in intra-abdominal adipose tissue volume during weight loss in obese men and women: correlation between magnetic resonance imaging and anthropometric measurements Int J Obes Relat Metab Disord 24 2000 607 613
24. O Lingjaerde, UG Ahlfors, P Bech, SJ Dencker, K Elgen The UKU side effect rating scale. A new comprehensive rating scale for psychotropic drugs and a cross-sectional study of side effects in neuroleptic-treated patients Acta Psychiatr Scand Suppl 334 1987 1 100
25. D Hedeker, RD Gibbons Longitudinal data analysis 2006 Wiley Hoboken, NJ
26. RE Kass, L Wasserman A reference Bayesian test for nested hypotheses and its relationship to the Schwartz criterion J Am Stat Assoc 90 1995 928 934
27. S Senn Testing for baseline balance in clinical trials Stat Med 13 1994 1715 1726
28. MD Miller, CF Paradis, PR Houck et al. Rating chronic medical illness burden in geropsychiatric practice and research: application of the Cumulative Illness Rating Scale Psychiatry Res 41 1992 237 248
29. SR Beach, CM Celano, PA Noseworthy, JL Januzzi, JC Huffman QTc prolongation, torsades de pointes, and psychotropic medications Psychosom Med 54 2013 1 13
30. C Randolph Repeatable Battery for the Assessment of Neuropsychological Status manual 1998 The Psychological Corporation San Antonio, TX
31. L Derogatis Brief Symptom Inventory (BSI): administration, scoring, and procedures manual 3rd edn. 1993 National Computer Systems Minneapolis, MN
32. NA Crossley, M Bauer Acceleration and augmentation of antidepressants with lithium for depressive disorders: two meta-analyses of randomized, placebo-controlled trials J Clin Psychiatry 68 2007 935 940
33. JC Nelson, K Delucchi, LS Schneider Efficacy of second generation antidepressants in late-life depression: a meta-analysis of the evidence Am J Geriatr Psychiatry 16 2008 558 567
34. CF Reynolds 3rd, E Frank, JM Perel et al. Nortriptyline and interpersonal psychotherapy as maintenance therapies for recurrent major depression: a randomized controlled trial in patients older than 59 years JAMA 281 1999 39 45
35. BJ Kinon, S Kollack-Walker, DG Jeste et al. Incidence of tardive dyskinesia in older adult patients treated with olanzapine or conventional antipsychotics J Geriatr Psychiatry Neurol 28 2014 67 79
36. E Weber, J Stack, BG Pollock et al. Weight change in older depressed patients during acute pharmacotherapy with paroxetine and nortriptyline: a double-blind randomised trial Am J Geriatr Psychiatry 8 2000 245 250
37. DW Haupt, PA Fahnestock, KA Flavin et al. Adiposity and insulin sensitivity derived from intravenous glucose tolerance tests in antipsychotic-treated patients Neuropsychopharmacology 32 2007 2561 2569
38. JM Amiel, CV Mangurian, R Ganguli, JW Newcomer Addressing cardiometabolic risk during treatment with antipsychotic medications Curr Opin Psychiatry 21 2008 613 618
39. RA Friedman Antidepressants' black-box warning - 10 years later N Engl J Med 371 2014 1666 1668
40. C Ballard, ML Hanney, M Theodoulou et al. The dementia antipsychotic withdrawal trial (DART-AD): long-term follow-up of a randomised placebo-controlled trial Lancet Neurol 8 2009 151 157
41. R Leontjevas, DL Gerritsen, M Smalbrugge, S Teerenstra, MJ Vernooij-Dassen, RT Koopmans A structural multidisciplinary approach to depression management in nursing-home residents: a multicentre, stepped-wedge cluster-randomised trial Lancet 381 2013 2255 2264